1887
  1. Home
  2. BSAVA Small Animal Formulary Part A: Canine and Feline
  3. Rabacfosadine
Rabacfosadine
; https://doi.org/
/content/dataitem/canine-and-feline/rabacfosadine

Rabacfosadine

Online Access: Subscribe
This is a drug monograph from the BSAVA Small Animal Formulary Part A: Canine and Feline. BSAVA members should login for access to the full monograph. Non-members can join BSAVA, buy a Formulary subscription, or buy the printed edition. 
  1. Cawley JR, Wright ZM, Meleo K et al. (2020) Concurrent use of rabacfosadine and L-asparaginase for relapsed or refractory multicentric lymphoma in dogs. Journal of Veterinary Internal Medicine 34, 882–889
    2.
  2. De Clercq E (2018) Tanovea® for the treatment of lymphoma in dogs. Biochemical Pharmacology 154, 265–269
  3. Saba CF, Vickery KR, Clifford CA et al. (2017) Rabacfosadine for relapsed canine B‐cell lymphoma: efficacy and adverse event profiles of 2 different doses. Veterinary and Comparative Oncology 16, 76–82
    4.
  4. Thamm DH (2024) Novel treatments for lymphoma. Veterinary Clinics of North America: Small Animal Practice 54, 477–490
    5.
  5. Thamm DH, Vail DM, Post GS et al. (2017) Alternating rabacfosadine/doxorubicin: efficacy and tolerability in naive canine multicentric lymphoma. Journal of Veterinary Internal Medicine 31, 872–878
    6.
  6. Weishaar KM, Wright ZM, Rosenberg MP et al. (2022) Multicenter, randomized, double-blinded, placebo-controlled study of rabacfosadine in dogs with lymphoma. Journal of Veterinary Internal Medicine 36, 215–226
    7.
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error